Search

Your search keyword '"Hooda, Amit"' showing total 138 results
Start Over Author "Hooda, Amit" Publication Type Academic Journals
138 results on '"Hooda, Amit"'

7. Impact of Clinical Presentation on Outcomes After Rotational Atherectomy in Patients Who Underwent Percutaneous Coronary Intervention

Author

Farooq, Ali, Koshy, Anoop N., Giustino, Gennaro, Sartori, Samantha, Snyder, Clayton, Hooda, Amit, Farhan, Serdar, Kyaw, Htoo, Khan, Mahin, Vinayak, Manish, Arora, Ayush, Dhulipala, Vishal, Suleman, Javed, Krishnamoorthy, Parasuram, Khera, Sahil, Sweeny, Joseph, Mehran, Roxana, Kini, Annapoorna S., and Sharma, Samin K.

Published
2023
Full Text
View/download PDF

9. Dielectric tunability of La2Ni1-xFexMnO6 double perovskites for energy storage applications.

Author

Hooda, Amit and Rathore, Mahendra Singh

Subjects
DIELECTRIC loss, X-ray photoelectron spectroscopy, ENERGY storage, PERMITTIVITY, TRANSMISSION electron microscopy
Abstract

The dielectric characteristics of double perovskite La2Ni1 − xFexMnO6; (x = 0, 0.2, 0.5, 0.8 & 1.0) developed via sol-gel route, were studied through analysis of B-site cation substitution. La2Ni0.8Fe0.2MnO6 attained a higher dielectric constant than pure La2NiMnO6 owing to comparatively higher B-site cationic disorder. The crystallite size and strain were determined using Williamson-Hall analysis, and strain in samples decreased with increasing Fe substitution. High-resolution transmission electron microscopy (HRTEM) authenticated the crystalline nature and selected area electron diffraction patterns (SAED) confirmed the purity of the sample. X-ray photoelectron spectroscopy (XPS) confirmed the co-occurrence of different oxidation states. Dielectric constant and tangent loss of overall composition decreased with frequency, while AC conductivity increased. AC conductivity decreased upon Fe-substitution and was strongly affected by the degree of B-site cationic disorder. Cole-cole plots and combined variation of Z″ & M″ with frequency suggested non-Debye relaxation in developed compositions. The tuned dielectric parameters suggest the possible applicability of developed double perovskite materials for fabricating energy storage devices. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

11. Outcomes Following Percutaneous Coronary Intervention in Patients With Multivessel Disease Who Were Recommended for But Declined Coronary Artery Bypass Graft Surgery.

Author

Koshy, Anoop N., Stone, Gregg W., Sartori, Samantha, Dhulipala, Vishal, Giustino, Gennaro, Spirito, Alessandro, Farhan, Serdar, Smith, Kenneth F., Yihan Feng, Vinayak, Manish, Salehi, Negar, Tanner, Richard, Hooda, Amit, Krishnamoorthy, Parasuram, Sweeny, Joseph M., Khera, Sahil, Dangas, George, Filsoufi, Farzan, Mehran, Roxana, and Kini, Annapoorna S.

Published
2024
Full Text
View/download PDF

14. F-49 | Long term outcomes according to lesion location and SYNTAX points, not attributed to the left main lesion, in patients undergoing percutaneous coronary intervention of the left main coronary artery

Author

Roumeliotis, Anastasios, Power, David A., Sartori, Samantha, Vogel, Birgit, Nicolas, Johny, Smith, Kenneth, Sweeny, Joseph, Krishnan, Prakash, Hooda, Amit, Suleman, Javed, Sharma, Raman, Krishnamoorthy, Parasuram Melarcode, Dangas, George D., Sharma, Samin K., Kini, Annapoorna S., and Mehran, Roxana

Published
2024
Full Text
View/download PDF

15. Transcatheter Aortic Valve Replacement: Current Status and Future Indications.

Author

Vinayak, Manish, Leone, Pier Pasquale, Tanner, Richard, Dhulipala, Vishal, Camaj, Anton, Makhija, Rakhee Rajendra Kumar, Hooda, Amit, Kini, Annapoorna S., Sharma, Samin K., and Khera, Sahil

Subjects
HEART valve prosthesis implantation, AORTIC stenosis, LONGEVITY
Abstract

In the past two decades, transcatheter aortic valve replacement (TAVR) has transformed the management of aortic stenosis and has become the standard of care regardless of surgical risk levels. Advances in transcatheter valve design across newer generations, improved imaging, greater operator expertise, and technical enhancements have collectively contributed to increased safety and a decline in procedural complications over this timeframe. The application of TAVR has progressively expanded to include younger patients with lower risks, who have longer life expectancies. This article offers an up-to-date review of the latest innovations in transcatheter delivery systems, devices, and its possible future indications. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

20. A Narrative Review on Periprocedural Stroke and Transcatheter Aortic Valve Replacement: Achilles’ Heel.

Author

Kodan, Parul, Khurana, Sakshi, Gulati, Amit, and Hooda, Amit

Subjects
STROKE treatment, STROKE prevention, PREVENTION of surgical complications, STROKE diagnosis, PERIOPERATIVE care, FIBRINOLYTIC agents, CEREBRAL embolism & thrombosis, HEART valve prosthesis implantation, STROKE, COMBINATION drug therapy, ORAL drug administration, AORTIC stenosis, THERAPEUTIC embolization, ANTICOAGULANTS, SEVERITY of illness index, INFECTIVE endocarditis, PLATELET aggregation inhibitors, PROSTHETIC heart valves, EARLY diagnosis, EARLY medical intervention, DISEASE risk factors
Abstract

Transcatheter aortic valve replacement (TAVR) has become the treatment option for symptomatic severe aortic stenosis patients across all risk profiles. Despite remarkable advancements in technology and operator experience, the occurrence of periprocedural stroke remains a significant concern, predominantly attributed to thromboembolic events in the immediate postprocedural period. To optimize patient outcomes, various strategies have been developed to minimize the risk of stroke, encompassing comprehensive preprocedural planning, effective management of comorbidities, utilization of cerebral embolic protection devices, and tailored medical therapy. This comprehensive review summarizes the currently available strategies for mitigating periprocedural stroke post‑TAVR and provides insights into future directions. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

23. SHOULD ADDITIONAL VESSELS BE TREATED DURING LEFT MAIN PERCUTANEOUS CORONARY INTERVENTION: INSIGHTS FROM A LARGE PROSPECTIVE REGISTRY

Author

Power, David, Roumeliotis, Anastasios, Camaj, Anton, Sartori, Samantha, Smith, Kenneth, Nicolas, Johny, Tanner, Richard, Makhija, Rakhee R, Leone, Pier Pasquale, Yasumura, Keisuke, Vinayak, Manish, Hooda, Amit, Krishnamoorthy, Parasuram Melarcode, Farhan, Serdar, Sweeny, Joseph Michael, Dangas, George D., Mehran, Roxana, Kini, Annapoorna Subhash, and Sharma, Samin K.

Published
2024
Full Text
View/download PDF

26. CLINICAL IMPACT OF PROCEDURAL COMPLEXITY AND HIGH BLEEDING RISK STATUS IN PATIENTS WITH CHRONIC KIDNEY DISEASE UNDERGOING PERCUTANEOUS CORONARY INTERVENTION

Author

Mehran, Roxana, Oliva, Angelo, Sartori, Samantha, Cao, Davide, Vogel, Birgit, Bay, Benjamin, Kim, Chan Joon, Feng, Yihan, Thapi, Roja, Nicolas, Johny, Hooda, Amit, Sharma, Raman, Sweeny, Joseph Michael, Stefanini, Giulio G., Dangas, George D., Kini, Annapoorna Subhash, and Sharma, Samin K.

Published
2024
Full Text
View/download PDF

27. IMPACT OF DIABETES MELLITUS ON 1-YEAR OUTCOMES OF BIODEGRADABLE VERSUS DURABLE POLYMER DRUG ELUTING STENTS IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION FOLLOWING ROTATIONAL ATHERECTOMY: RESULTS FROM LARGE PROSPECTIVE REGISTRY

Author

Makhija, Rakhee R, Siano, Matthew, Patel, Neelkumar, Farhan, Serdar, Power, David, Sartori, Samantha, Feng, Yihan, Cheng, Wen, Camaj, Anton, Dhulipala, Vishal, Yasumura, Keisuke, Thapi, Roja, Vijay, Pooja, Gurung, Nikito, Vinayak, Manish, Hooda, Amit, Krishnamoorthy, Parasuram Melarcode, Sweeny, Joseph Michael, Dangas, George D., Mehran, Roxana, Kini, Annapoorna Subhash, and Sharma, Samin K.

Published
2024
Full Text
View/download PDF

29. OUTCOMES OF PATIENTS WITH DIABETES MELLITUS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION STRATIFIED BY TREATMENT WITH OR WITHOUT GLUCAGON LIKE PEPTIDE 1 RECEPTOR AGONISTS

Author

Penta, Bhavanadhar, Farhan, Serdar, Sartori, Samantha, Dhulipala, Vishal, Vijay, Pooja, Gurung, Nikito, Feng, Yihan, Vinayak, Manish, Hooda, Amit, Sharma, Raman, Krishnamoorthy, Parasuram Melarcode, Kapur, Vishal, Sweeny, Joseph Michael, Mehran, Roxana, Kini, Annapoorna Subhash, and Sharma, Samin K.

Published
2024
Full Text
View/download PDF

30. IMPACT OF POLYVASCULAR DISEASE ON MORTALITY IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION FOR UNPROTECTED LEFT MAIN CORONARY ARTERY DISEASE

Author

Bay, Benjamin, Roumeliotis, Anastasios, Sartori, Samantha, Power, David, Vogel, Birgit, Smith, Kenneth, Thapi, Roja, Nicolas, Johny, Kim, Chan Joon, Oliva, Angelo, Cao, Davide, Hooda, Amit, Sharma, Raman, Sweeny, Joseph Michael, Krishnan, Prakash, Dangas, George D., Kini, Annapoorna Subhash, Sharma, Samin K., and Mehran, Roxana

Published
2024
Full Text
View/download PDF

31. INFLAMMATION AND CONTRAST ASSOCIATED ACUTE KIDNEY INJURY IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION

Author

Nicolas, Johny, Dangas, George D., Sartori, Samantha, Feng, Yihan, Vogel, Birgit, Camaj, Anton, Beerkens, Frans, Power, David, Roumeliotis, Anastasios D., Oliva, Angelo, Bay, Benjamin, Fisher, Rebecca, Byrne, Katie Kenny, Sharma, Raman, Sweeny, Joseph Michael, Hooda, Amit, Kapur, Vishal, Serrao, Gregory, Kini, Annapoorna Subhash, Sharma, Samin K., and Mehran, Roxana

Published
2024
Full Text
View/download PDF

32. Ticagrelor vs Prasugrel in a Contemporary Real-World Cohort Undergoing Percutaneous Coronary Intervention.

Author

Koshy, Anoop N., Giustino, Gennaro, Sartori, Samantha, Kyaw, Htoo, Yadav, Mayank, Zhang, Zhongjie, Hooda, Amit, Farooq, Ali, Krishnamoorthy, Parasuram, Sweeny, Joseph M., Khera, Sahil, Serrao, Gregory W., Sharma, Raman, Suleman, Javed, Dangas, George, Kini, Annapoorna S., Mehran, Roxana, and Sharma, Samin K.

Abstract

Potent P2Y 12 agents such as ticagrelor and prasugrel are increasingly utilized across the clinical spectrum of patients undergoing percutaneous coronary intervention (PCI). There is a paucity of data supporting their use in a patient population inclusive of both acute coronary syndrome (ACS) and chronic coronary syndrome (CCS) patients. The authors compared the efficacy and safety of ticagrelor and prasugrel in a real-world contemporary PCI cohort. Consecutive patients undergoing PCI between 2014 and 2019 discharged on either prasugrel or ticagrelor were included from the prospectively collected institutional PCI registry. Primary endpoint was the composite of death and myocardial infarction (MI), with secondary outcomes including rates of bleeding, stroke, and target vessel revascularization at 1 year. Overall, 3,858 patients were included in the study (ticagrelor: n = 2,771; prasugrel: n = 1,087), and a majority (48.4%) underwent PCI in the context of CCS. Patients prescribed ticagrelor were more likely to be female, have a history of cerebrovascular disease, and have ACS presentation, while those receiving prasugrel were more likely to be White with a higher prevalence of prior revascularization. No difference in the risk of death or MI was noted across the groups (ticagrelor vs prasugrel: 3.3% vs 3.1%; HR: 0.88; 95% CI: 0.54-1.43; P = 0.59). Rates of target vessel revascularization were significantly lower in the ticagrelor cohort (9.3% vs 14.0%; adjusted HR: 0.71; 95% CI: 0.55-0.91; P = 0.007) with no differences in stroke or bleeding. The results were consistent in patients with CCS (HR: 0.84; 95% CI: 0.46-1.54) and ACS (HR: 1.18; 95% CI: 0.46-1.54), without evidence of interaction (P = 0.37), and confirmed across multivariable adjustment and propensity score stratification analysis. In this contemporary patient population undergoing PCI, prasugrel and ticagrelor were associated with similar 1-year efficacy and safety. [Display omitted] [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

37. TCT-511 Impact of Adjunctive Intravascular Imaging on Cardiovascular Outcomes in Unprotected Left Main Percutaneous Coronary Intervention at a High-Volume Center

Author

Power, David, Roumeliotis, Anastasios, Camaj, Anton, Nicolas, Johny, Sartori, Samantha, Smith, Kenneth, Beerkens, Frans, Edens, Madison, Tanner, Richard, Minatoguchi, Shingo, Yasumura, Keisuke, Dhulipala, Vishal, Suleman, Javed, Vogel, Birgit, Hooda, Amit, Kapur, Vishal, Sharma, Raman, Krishnamoorthy, Parasuram, Sweeny, Joseph, Kini, Annapoorna, Sharma, Samin, Mehran, Roxana, and Dangas, George

Published
2023
Full Text
View/download PDF

38. TCT-509 Impact of Coronary Trifurcation Anatomy on Cardiovascular Outcomes in Unprotected Left Main Percutaneous Coronary Intervention.

Author

Power, David, Roumeliotis, Anastasios, Camaj, Anton, Sartori, Samantha, Smith, Kenneth, Yasumura, Keisuke, Minatoguchi, Shingo, Hooda, Amit, Kapur, Vishal, Suleman, Javed, Sharma, Raman, Dhulipala, Vishal, Tanner, Richard, Vogel, Birgit, Krishnamoorthy, Parasuram, Sweeny, Joseph, Kini, Annapoorna, Sharma, Samin, Mehran, Roxana, and Dangas, George

Published
2023
Full Text
View/download PDF

41. TAVR - From inoperable to younger, lower-risk patients: A slippery slope?

Author

Unbehaun, Axel, Abdullah, Mohamed, Hooda, Amit, Gedela, Maheedhar, Kempfert, Joerg, Klein, Christoph, and Tang, Gilbert H.L.

Abstract

Despite current valve guidelines recommending both transcatheter and surgical aortic valve replacement (TAVR and SAVR, respectively) in patients with symptomatic severe aortic stenosis (AS), TAVR has recently become the preferred treatment over SAVR, driven by its minimal invasiveness, faster recovery and earlier improvement in quality of life. However, several limitations and unresolved issues remain with TAVR, including stroke, conduction system disorder, durability, bicuspid anatomy, coronary reaccess and lifetime management with aortic valve reintervention. Our review aims to highlight the above issues and discuss them in depth, to demonstrate the complementary role of TAVR and SAVR in the treatment of AS. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

42. Outcomes and feasibility of redo‐TAVR after Sapien 3 Ultra TAVR in extremely‐undersized versus nominally‐sized annuli.

Author

Tang, Gilbert H. L., Hooda, Amit, Zaid, Syed, Chuang, Ming‐Yu, Khera, Sahil, Krishnamoorthy, Parasuram, Lerakis, Stamatios, Anastasius, Malcolm, Ahmad, Hasan A., Goldberg, Joshua B., Akodad, Mariama, Wood, David A., Leipsic, Jonathon A., Blanke, Philipp, Dangas, George D., Sharma, Samin K., Kini, Annapoorna S., Webb, John G., and Sathananthan, Janarthanan

Published
2022
Full Text
View/download PDF

43. TICAGRELOR OR PRASUGREL VERSUS CLOPIDOGREL IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION FOR CHRONIC CORONARY SYNDROMES: RESULTS FROM A REAL-WORLD REGISTRY

Author

Koshy, Anoop Ninan, Giustino, Gennaro, Sartori, Samantha, Hooda, Amit, Feng, Yihan, Snyder, Clayton, Smith, Kenneth, Kumar, Kartik, Chen, Shiwei, Krishnamoorthy, Parasuram Melarcode, Dhulipala, Vishal, Sweeny, Joseph M., Khera, Sahil, Serrao, Gregory, Sharma, Raman, Dangas, George D., Kini, Annapoorna Subhash, Mehran, Roxana, and Sharma, Samin K.

Published
2023
Full Text
View/download PDF

48. Intricate interplay between Covid‐19 and cardiovascular diseases.

Author

Keri, Vishakh C., Hooda, Amit, Kodan, Parul, R L, Brunda, Jorwal, Pankaj, and Wig, Naveet

Abstract

Summary: Covid‐19 disease can involve any organ system leading to myriad manifestations and complications. Cardiovascular manifestations are being increasingly recognised with the improved understanding of the disease. Acute coronary syndrome, myocarditis, arrhythmias, cardiomyopathy; heart failure and thromboembolic disease have all been described. The elderly and those with prior cardiac diseases are at an increased risk of mortality. Overlapping symptomatology, ability of drugs to cause QTc interval (start of Q wave to the end of T wave) prolongation on electrocardiogram and arrhythmias, potential drug interactions, the need to recognise patients requiring urgent definitive management and provide necessary bedside interventions without increasing the risk of nosocomial spread have made the management challenging. In the background of a pandemic, non‐Covid‐19 cardiac patients are affected by delayed treatment and nosocomial exposure. Triaging using telemedicine and artificial intelligence along with utilization of bedside rapid diagnostic tests to detect Covid‐19 could prove helpful in this aspect. [ABSTRACT FROM AUTHOR]

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results